OBJECTIVE- To determine whether depression symptoms or antidepressant medication use predicts weight regain in ovetweight individuals with impaired glucose tolerance (IGT) who are successful with initial weight loss. RESEARCH DESIGN AND METHODS-A total of 1,442 panicipams who successfully lost atleast3 % of their baseline body weight after 12 months of panicipation in the randomized controlled Diabetes Prevention Program (DPP) continued in their assigned treatment group (metformin, intensive lifestyle, or placebo) and were followed into the Diabetes Prevention Pro-gram Outcome Study (DPPOS). Weight regain was defined as a return to baseline DPP body weight. Panicipant weight and antidepressant medication use were assessed every 6 months. De...
with impaired glucose tolerance with metformin>3.2 years reduced the risk of developing type 2 di...
Clinical efficacy of a medically supervised outpatient high-protein, low-calorie diet program is equ...
Background and objectives Comorbid major depression is associated with adverse health outcomes in pa...
OBJECTIVE: To determine whether depression symptoms or antidepressant medication use predicts weigh...
OBJECTIVEdTo determine whether depression symptoms or antidepressant medication use predicts weight ...
Objective: To determine whether the level of depressive symptoms is associated with poor glycemic co...
Background: Besides being an organic disease, Diabetes Mellitus (DM) is a condition with psychiatric...
Objective: symptoms of depression severe enough to warrant treatment are encountered in one of every...
OBJECTIVE: Antidepressant medication use (ADM) has been shown to predict diabetes. This article a...
OBJECTIVE: Although behavioral weight loss interventions generally have been shown to improve depres...
L Xiao1, V Yank1,2, SR Wilson1,2, PW Lavori3 and J Ma1,2 OBJECTIVE: To investigate whether the effec...
Copyright © 2015 AdhamMottalib et al. This is an open access article distributed under the Creative ...
The researchers conducted this study to test the hypothe-sis that risk of type 2 diabetes is less fo...
Contains fulltext : 88832.pdf (publisher's version ) (Closed access)OBJECTIVES: To...
OBJECTIVE: To assess depression markers (symptoms and antidepressant medicine use) in Diabetes Prev...
with impaired glucose tolerance with metformin>3.2 years reduced the risk of developing type 2 di...
Clinical efficacy of a medically supervised outpatient high-protein, low-calorie diet program is equ...
Background and objectives Comorbid major depression is associated with adverse health outcomes in pa...
OBJECTIVE: To determine whether depression symptoms or antidepressant medication use predicts weigh...
OBJECTIVEdTo determine whether depression symptoms or antidepressant medication use predicts weight ...
Objective: To determine whether the level of depressive symptoms is associated with poor glycemic co...
Background: Besides being an organic disease, Diabetes Mellitus (DM) is a condition with psychiatric...
Objective: symptoms of depression severe enough to warrant treatment are encountered in one of every...
OBJECTIVE: Antidepressant medication use (ADM) has been shown to predict diabetes. This article a...
OBJECTIVE: Although behavioral weight loss interventions generally have been shown to improve depres...
L Xiao1, V Yank1,2, SR Wilson1,2, PW Lavori3 and J Ma1,2 OBJECTIVE: To investigate whether the effec...
Copyright © 2015 AdhamMottalib et al. This is an open access article distributed under the Creative ...
The researchers conducted this study to test the hypothe-sis that risk of type 2 diabetes is less fo...
Contains fulltext : 88832.pdf (publisher's version ) (Closed access)OBJECTIVES: To...
OBJECTIVE: To assess depression markers (symptoms and antidepressant medicine use) in Diabetes Prev...
with impaired glucose tolerance with metformin>3.2 years reduced the risk of developing type 2 di...
Clinical efficacy of a medically supervised outpatient high-protein, low-calorie diet program is equ...
Background and objectives Comorbid major depression is associated with adverse health outcomes in pa...